Annual CFF
-$3.96B$1.28B+24.44%
Summary
- Current Value
- As of today, GSK annual cash from financing is -$3.96B, up +24.44% on
- Historical Performance
- GSK annual cash from financing is down -293.39% over the past 3 years, up +66.68% over the past 5 years
- All-Time High Comparison
- GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on
- 3-Year Low Comparison
- GSK annual cash from financing is +34.72% above its 3-year low of -$6.07B reached on
- Sector Comparison
- GSK annual cash from financing is higher than 1.74% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Quarterly Cash From Financing | $1.09B | +228.9% | +183.1% | +143.1% | +184.5% | |
| TTM Cash From Financing | -$2.15B | +59.3% | -206.4% | +81.9% | +70.9% | |
| Price | $53.84 | +39.8% | +53.6% | +44.0% | +40.0% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Annual Dividends Paid | $3.38B | +8.2% | -20.9% | -33.7% | -31.7% | |
| Annual Total Debt | $23.83B | +12.0% | -5.6% | -35.8% | +0.8% | |
| Shares Outstanding | 2.02B | -0.6% | -1.3% | +0.4% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.05B | N/A | -293.4% |
| 5Y | $2.05B | -293.4% | |
| All | $4.90B | -180.8% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$6.07B | +34.7% | |
| 5Y | -$11.89B | N/A | +66.7% |
| All | -$11.89B | +66.7% |
Cash From Financing History
FAQ
What is the current annual cash from financing of GSK?
As of today, GSK annual cash from financing is -$3.96B
What is 1-year change in GSK annual cash from financing?
GSK annual cash from financing is up +24.44% year-over-year
What is 3-year change in GSK annual cash from financing?
GSK annual cash from financing is down -293.39% over the past 3 years
How far is GSK annual cash from financing from its all-time high?
GSK annual cash from financing is currently -180.82% below its historical high of $4.90B set on December 31, 2018
How does GSK annual cash from financing rank versus sector peers?
GSK annual cash from financing is higher than 1.74% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFF
$1.09B$2.80B+163.77%
Summary
- Current Value
- As of today, GSK quarterly cash from financing is $1.09B, up +163.77% on
- Historical Performance
- GSK quarterly cash from financing is up +228.89% year-over-year, up +183.09% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from financing is currently -90.63% below its historical high of $11.63B set on
- 3-Year Low Comparison
- GSK quarterly cash from financing is +126.81% above its 3-year low of -$4.06B reached on
- Sector Comparison
- GSK quarterly cash from financing is higher than 99.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $1.09B | +163.8% | +228.9% | +183.1% | +143.1% | |
| Annual Cash From Financing | -$3.96B | – | +24.4% | -293.4% | +66.7% | |
| TTM Cash From Financing | -$2.15B | +47.3% | +59.3% | -206.4% | +81.9% | |
| Price | $53.84 | +9.7% | +39.8% | +53.6% | +44.0% | |
| Quarterly Cash From Operations | $2.74B | -9.5% | -3.2% | +56.8% | -40.7% | |
| Quarterly Cash From Investing | -$3.18B | -47.9% | -110.9% | -726.8% | -7400.6% | |
| Quarterly Dividends Paid | $846.84M | -6.6% | +2.0% | +21.5% | -34.2% | |
| Quarterly Total Debt | $23.83B | -0.3% | +12.0% | -5.6% | -35.8% | |
| Shares Outstanding | 2.02B | – | -0.6% | -1.3% | +0.4% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.24B | -12.2% | |
| 3Y | $1.24B | -12.2% | |
| 5Y | $10.79B | -89.9% | |
| All | $11.63B | -90.6% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.78B | +139.2% | |
| 3Y | -$4.06B | +126.8% | |
| 5Y | -$5.70B | +119.1% | |
| All | -$5.70B | +119.1% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of GSK?
As of today, GSK quarterly cash from financing is $1.09B
What is GSK quarterly cash from financing most recent change?
GSK quarterly cash from financing was up +163.77% on December 31, 2025
What is 1-year change in GSK quarterly cash from financing?
GSK quarterly cash from financing is up +228.89% year-over-year
How far is GSK quarterly cash from financing from its all-time high?
GSK quarterly cash from financing is currently -90.63% below its historical high of $11.63B set on June 30, 2018
How does GSK quarterly cash from financing rank versus sector peers?
GSK quarterly cash from financing is higher than 99.44% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFF
-$2.15B$1.93B+47.30%
Summary
- Current Value
- As of today, GSK TTM cash from financing is -$2.15B, up +47.30% on
- Historical Performance
- GSK TTM cash from financing is up +59.30% year-over-year, down -206.36% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from financing is currently -121.31% below its historical high of $10.11B set on
- 3-Year Low Comparison
- GSK TTM cash from financing is +76.42% above its 3-year low of -$9.14B reached on
- Sector Comparison
- GSK TTM cash from financing is higher than 2.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$2.15B | +47.3% | +59.3% | -206.4% | +81.9% | |
| Annual Cash From Financing | -$3.96B | – | +24.4% | -293.4% | +66.7% | |
| Quarterly Cash From Financing | $1.09B | +163.8% | +228.9% | +183.1% | +143.1% | |
| Price | $53.84 | +9.7% | +39.8% | +53.6% | +44.0% | |
| TTM Cash From Operations | $9.66B | -0.9% | +22.9% | +19.4% | -1.4% | |
| TTM Cash From Investing | -$7.74B | -27.6% | -331.9% | +28.3% | -388.5% | |
| TTM Dividends Paid | $3.39B | +0.5% | +7.6% | -19.9% | -33.4% | |
| Quarterly Total Debt | $23.83B | -0.3% | +12.0% | -5.6% | -35.8% | |
| Shares Outstanding | 2.02B | – | -0.6% | -1.3% | +0.4% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.15B | at high | |
| 3Y | $2.03B | N/A | -206.4% |
| 5Y | $3.19B | -167.4% | |
| All | $10.11B | -121.3% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$5.29B | N/A | +59.3% |
| 3Y | -$9.14B | +76.4% | |
| 5Y | -$12.43B | +82.7% | |
| All | -$12.43B | +82.7% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of GSK?
As of today, GSK TTM cash from financing is -$2.15B
What is GSK TTM cash from financing most recent change?
GSK TTM cash from financing was up +47.30% on December 31, 2025
What is 1-year change in GSK TTM cash from financing?
GSK TTM cash from financing is up +59.30% year-over-year
How far is GSK TTM cash from financing from its all-time high?
GSK TTM cash from financing is currently -121.31% below its historical high of $10.11B set on March 31, 2019
How does GSK TTM cash from financing rank versus sector peers?
GSK TTM cash from financing is higher than 2.42% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk